ASIA PATHOGENOMICS - Metagenomic Next-Generation Sequencing: A non-culture based, hypothesis-free, precision diagnosis for infectious disease

Patients with severe infectious disease usually lack of appropriate timely treatment be cause of “low positive rate” and “long turn-around time” in conventional clinical test.

Metagenomic next-generation sequencing (mNGS) is a new pathogen detection method provide “Comprehensive”, “Precise” and “Fast” clinical data in one single test. mNGS could help physicians to adjust the medications of anti-infective agents timely and improve the quality of healthcare for patients.

Clinical unmet need:

Limitations of conventional clinical test such as “low pathogen coverage”, “low detection rate” and “long turn-around time”are barriers to timely support for diagnose, which might cause the difficulty to adjust or withdraw the medication of anti-infective agents.

Advantages of metagenomic next-generation sequencing (mNGS):

1.Comprehensive:

mNGS can identify up to 12,593 kinds of pathogens in one single test. (including bacteria, virus, fungi, parasites, MTB and atypical pathogens)

2.Precise:

mNGS detection rate was 60% higher than blood culture and was independent of antibiotic treatment.

3. Fast:

mNGS can dramatically shorten the turn-around time.

ASIA PATHOGENOMICS’ high class medical laboratory:

The very first pathogen detecting mNGS precision medical laboratory in Taiwan biotechnology industry.

1. P2 level combine with negative pressure laboratory cubicle

Avoid environmental pollution and awareness of biosafety.

2.Isolated sample transfer system

Reduce the risk of sample cross-contamination.

 Look for: 

ASIA PATHOGENOMICS official website & facebook

Metagenomic next-generation sequencing (mNGS) service：

Sample type includes plasma, BSF, BALF, sputum, swab and tissue.

 Booth No. L331